Inge Van der Sluis

15PUBLICATIONS
64CO-AUTHORS
Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer geneticsNeonatologyPaediatrics not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Feb 27, 2026
Drivers of Methotrexate Polyglutamate Concentration in Erythrocytes: Insights from Immune-Mediated Inflammatory Diseases and Pediatric Acute Lymphoblastic Leukemia.

Janani Sundaresan, Wout J Hamelink, Renske C F Hebing

|Jan 08, 2026
Sustained Benefit of Blinatumomab in Infants With <i>KMT2A</i>-Rearranged ALL: Long-Term Outcomes, Toxicity, and Pharmacokinetics.

Miguel Vieira Martins, Paola de Lorenzo, Rishi S Kotecha

|Feb 28, 2025
Challenging Conventional Diagnostic Methods by Comprehensive Molecular Diagnostics: A Nationwide Prospective Comparison in Children With ALL.

Judith M Boer, Marco J Koudijs, Lennart A Kester

|Jun 26, 2024
Severe steroid-related neuropsychiatric symptoms during paediatric acute lymphoblastic leukaemia therapy-An observational Ponte di Legno Toxicity Working Group Study.

Stavroula Anastasopoulou, Gemma Swann, Liv Andres-Jensen

|Feb 02, 2024
Continuous PEGasparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL: A Dutch Childhood Oncology Group ALL11 Randomized Trial.

Inge M van der Sluis, Leiah J Brigitha, Marta Fiocco

|Nov 30, 2023
Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921.

Erica Brivio, Edoardo Pennesi, Marieke E Willemse

Pageof 3

Frequent Collaborators

4 joint publications

Rob Pieters

3 joint publications

Monique L den Boer

3 joint publications

Franco Locatelli

3 joint publications

Valerie de Haas